Tutorials

Shares were mostly lower in Asia on Monday on concern over a resurgence of coronavirus cases and pessimism after Wall Street posted its worst week in nearly three months. Benchmarks in Tokyo, Sydney and Shanghai fell after China reported an outbreak of new infections in Beijing and reimposed precautions to prevent it from spreading. Stocks are turning wobbly as investors re-evaluate their expectations for economic growth, which many skeptics have been saying were overly optimistic. Read More

Reliance Industries’ shares offered in the just-concluded rights issue will be listed on stock exchanges on Monday, concluding the issue in just 42 days. “Effective from Monday, June 15, 2020, the new securities of Reliance Industries Ltd (Scrip Code: 890147) shall be listed and permitted to trade on the Exchange in the list of ‘A’ Group of Securities,” BSE said. RIL completed the allotment of partly paid-up shares to the demat accounts of its shareholders Read More

Concentration of ownership after delisting may create governance and key-man issues at the companies adopting such strategies, ratings agency Fitch warned on Thursday. Corporates can also simplify or reorganise complex group structures without the interference of minority shareholders through such moves, the agency noted. Anil Agarwal-led Vedanta Resources and HT Global IT Solutions Holdings have announced delisting of their Indian subsidiaries Vedanta and Hexaware Technologies, respectively – amid a slump in share prices and easing Read More

Panacea Biotec share price hits 20 per cent upper circuit at Rs 202.80 apiece on BSE after the biotechnology company announced a collaboration with US-based Refana for coronavirus vaccine on Tuesday. The stock is just 3.7 per cent away from its 52-week high level of Rs 210.60 hit in April this year. “Panacea Biotec Ltd is delighted to announce the landmark collaboration with Refana Inc. USA for Covid-19 vaccine which will enable global development, manufacturing Read More

Even as the government started gradually easing the coronavirus-induced lockdown restrictions, the Indian share market has been witnessing huge volatility. From an all-time high of 42,273, BSE Sensex plunged to a 52-week low of 25, 638 only to march northward to reclaim its crucial level of 34,000. These tumultuous times in the stock market have proved to be an opportunity for the investors to bet on blue-chips companies which are available at throw-out prices. Research Read More